Cargando…
Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata
BACKGROUND: Uterine leiomyomata (UL), commonly known as uterine fibroids, are benign smooth muscle tumors of the myometrium. They cause pelvic pain, abnormal uterine bleeding, and infertility in women of reproductive age. The ovarian hormone estrogen is the main stimulator for the fibroid growth. Th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607871/ https://www.ncbi.nlm.nih.gov/pubmed/34900640 http://dx.doi.org/10.18502/jri.v22i3.6720 |
_version_ | 1784602647076012032 |
---|---|
author | Firdaus, Ruqia Agrawal, Prabha Anagani, Manjula Vijayalakshmi, Kodati Hasan, Qurratulain |
author_facet | Firdaus, Ruqia Agrawal, Prabha Anagani, Manjula Vijayalakshmi, Kodati Hasan, Qurratulain |
author_sort | Firdaus, Ruqia |
collection | PubMed |
description | BACKGROUND: Uterine leiomyomata (UL), commonly known as uterine fibroids, are benign smooth muscle tumors of the myometrium. They cause pelvic pain, abnormal uterine bleeding, and infertility in women of reproductive age. The ovarian hormone estrogen is the main stimulator for the fibroid growth. The etiology is not yet clearly understood; however, UL are believed to be monoclonal tumors arising from a common progenitor cell. Chromosomal cytogenetic abnormalities have been demonstrated in 40–50% of the fibroids. The most frequent tumor specific genetic alterations in UL were identified in exon-2 of Mediator Complex Subunit 12 (MED-12). METHODS: In the present study, twenty-two multiple fibroids were evaluated both from the same uterus and from different uteri, of four women, for somatic mutations in hotspot region of MED-12. The tissue DNA of the UL’s was isolated, amplified by PCR visualized on gel and sent for Sanger sequencing. RESULTS: The results indicate several variants in exon-2 and flanking intronic regions, seven exonic variants and five intronic variants which provide evidence that multiple UL in the same uterus may not be clonal in origin. CONCLUSION: This study indicates genetic heterogeneity. UL may not have a clonal origin, these exon-2 variants of MED-12 gene could be involved in UL progression. |
format | Online Article Text |
id | pubmed-8607871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Avicenna Research Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-86078712021-12-09 Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata Firdaus, Ruqia Agrawal, Prabha Anagani, Manjula Vijayalakshmi, Kodati Hasan, Qurratulain J Reprod Infertil Original Article BACKGROUND: Uterine leiomyomata (UL), commonly known as uterine fibroids, are benign smooth muscle tumors of the myometrium. They cause pelvic pain, abnormal uterine bleeding, and infertility in women of reproductive age. The ovarian hormone estrogen is the main stimulator for the fibroid growth. The etiology is not yet clearly understood; however, UL are believed to be monoclonal tumors arising from a common progenitor cell. Chromosomal cytogenetic abnormalities have been demonstrated in 40–50% of the fibroids. The most frequent tumor specific genetic alterations in UL were identified in exon-2 of Mediator Complex Subunit 12 (MED-12). METHODS: In the present study, twenty-two multiple fibroids were evaluated both from the same uterus and from different uteri, of four women, for somatic mutations in hotspot region of MED-12. The tissue DNA of the UL’s was isolated, amplified by PCR visualized on gel and sent for Sanger sequencing. RESULTS: The results indicate several variants in exon-2 and flanking intronic regions, seven exonic variants and five intronic variants which provide evidence that multiple UL in the same uterus may not be clonal in origin. CONCLUSION: This study indicates genetic heterogeneity. UL may not have a clonal origin, these exon-2 variants of MED-12 gene could be involved in UL progression. Avicenna Research Institute 2021 /pmc/articles/PMC8607871/ /pubmed/34900640 http://dx.doi.org/10.18502/jri.v22i3.6720 Text en Copyright© 2021, Avicenna Research Institute. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Original Article Firdaus, Ruqia Agrawal, Prabha Anagani, Manjula Vijayalakshmi, Kodati Hasan, Qurratulain Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata |
title | Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata |
title_full | Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata |
title_fullStr | Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata |
title_full_unstemmed | Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata |
title_short | Multiple Mutations in Exon-2 of Med-12 Identified in Uterine Leiomyomata |
title_sort | multiple mutations in exon-2 of med-12 identified in uterine leiomyomata |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607871/ https://www.ncbi.nlm.nih.gov/pubmed/34900640 http://dx.doi.org/10.18502/jri.v22i3.6720 |
work_keys_str_mv | AT firdausruqia multiplemutationsinexon2ofmed12identifiedinuterineleiomyomata AT agrawalprabha multiplemutationsinexon2ofmed12identifiedinuterineleiomyomata AT anaganimanjula multiplemutationsinexon2ofmed12identifiedinuterineleiomyomata AT vijayalakshmikodati multiplemutationsinexon2ofmed12identifiedinuterineleiomyomata AT hasanqurratulain multiplemutationsinexon2ofmed12identifiedinuterineleiomyomata |